Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,377 | 5,451 | 12,750 | 6,047 | 30,131 |
| Receivables | 308 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 22,092 |
| TOTAL | $8,242 | $5,838 | $13,087 | $6,379 | $53,621 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 335 |
| Intangibles | 1,914 | 1,914 | 1,914 | 0 | 15,153 |
| Other Non-Current Assets | 6,453 | 9,163 | 18,525 | 41 | 13,035 |
| TOTAL | $8,367 | $11,077 | $20,439 | $41 | $28,523 |
| Total Assets | $16,609 | $16,915 | $33,526 | $6,420 | $82,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 8,377 | 1,709 | 4,739 |
| Accounts payable and accrued liabilities | 3,902 | 3,755 | 12,991 | 0 | 26,597 |
| Accrued Expenses | 1,171 | 2,219 | 3,201 | 4,049 | 5,292 |
| Other current liabilities | N/A | N/A | N/A | N/A | 14,518 |
| TOTAL | $5,290 | $5,974 | $24,569 | $5,758 | $57,071 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,611 | N/A | N/A |
| Other Non-Current Liabilities | 4,964 | 5,339 | 2,603 | 5,659 | 6,142 |
| TOTAL | $5,226 | $5,696 | $6,887 | $5,659 | $11,560 |
| Total Liabilities | $10,516 | $11,670 | $31,456 | $11,417 | $68,631 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,718 | 464 | 131 | 24 | 6 |
| Common Shares | 1 | 1 | 1 | N/A | 15 |
| Retained earnings | -101,147 | -81,855 | -54,185 | -30,431 | -279,383 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 151 |
| TOTAL | $6,093 | $5,245 | $2,070 | $-4,997 | $13,513 |
| Total Liabilities And Equity | $16,609 | $16,915 | $33,526 | $6,420 | $82,144 |